| Title : Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid - Bloniecki_2017_J.Alzheimers.Dis_57_387 |
| Author(s) : Bloniecki V , Aarsland D , Blennow K , Cummings J , Falahati F , Winblad B , Freund-Levi Y |
| Ref : J Alzheimers Dis , 57 :387 , 2017 |
| Abstract : Bloniecki_2017_J.Alzheimers.Dis_57_387 |
| ESTHER : Bloniecki_2017_J.Alzheimers.Dis_57_387 |
| PubMedSearch : Bloniecki_2017_J.Alzheimers.Dis_57_387 |
| PubMedID: 28269767 |
Bloniecki V, Aarsland D, Blennow K, Cummings J, Falahati F, Winblad B, Freund-Levi Y (2017)
Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid
J Alzheimers Dis
57 :387
Bloniecki V, Aarsland D, Blennow K, Cummings J, Falahati F, Winblad B, Freund-Levi Y (2017)
J Alzheimers Dis
57 :387